• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌的结节内结节样结构:肝胆期强化模式和病理特征。

Nodule-in-nodule architecture of hepatocellular carcinomas: enhancement patterns in the hepatobiliary phase and pathological features.

机构信息

Department of Radiology, Third Affiliated Hospital of Nantong University and Nantong Third People's Hospital, #99 Youth Middle Road, Chongchuan District, Nantong, 226000, Jiangsu, China.

Department of Pathology, Third Affiliated Hospital of Nantong University and Nantong Third People's Hospital, #99 Youth Middle Road, Chongchuan District, Nantong, 226000, Jiangsu, China.

出版信息

Abdom Radiol (NY). 2024 Nov;49(11):3834-3846. doi: 10.1007/s00261-024-04259-y. Epub 2024 Jun 24.

DOI:10.1007/s00261-024-04259-y
PMID:38913136
Abstract

PURPOSE

This study aimed to evaluate the enhancement patterns in the hepatobiliary phase (HBP) and pathological features of nodule-in-nodule-type hepatocellular carcinoma (NIN-HCC) patients.

METHODS

In this single-institution retrospective study, 27 consecutive cirrhosis patients with 29 histologically confirmed NIN-HCCs who underwent preoperative examination via Gd-EOB-DTPA-enhanced MRI were enrolled from January 2016 to September 2023. Two blinded radiologists assessed the imaging features of both the inner and outer nodules in NIN-HCCs to reach a consensus on the Liver Imaging Reporting & Data System (LI-RADS) categories of the lesions. Based on the different enhancement patterns of the inner and outer nodules in the HBP, NIN-HCCs were classified into different groups and further divided into different types. Imaging features and LI-RADS categories were subsequently compared among the groups. Pathological findings for NIN-HCCs were also evaluated.

RESULTS

Among 29 NIN-HCCs, all inner nodules showed hypervascularity, with a maximum diameter of 13.2 ± 5.5 mm; 51.7% (15/29) showed "wash-in with washout" enhancement; and 48.3% (14/29) showed "wash-in without washout" enhancement. All outer nodules showed hypovascularity, with a maximum diameter of 25.6 ± 7.3 mm, and 51.9% (14/29) showed a washout appearance on PVP. Among all the lesions, the maximum diameter was 27.5 ± 6.8 mm; 12 (41.4%) lesions were LR-4, and 17 (58.6%) lesions were LR-5. NIN-HCCs were classified into hypointense (62.1%, 18/29) and isointense (37.9%, 11/29) groups based on the signal intensity of the outer nodules in the HBP. In the hypointense group, 2 (6.9%) of the inner nodules were hypointense (type A), 11 (37.9%) were isointense (type B), and 5 (17.2%) were hyperintense (type C) compared to the background hypointense outer nodules. In the isointense group, 9 (31.0%) of the inner nodules were hypointense (type D), 2 (6.9%) were isointense (type E), and no (0%) was hyperintense (type F) compared to the background isointense outer nodules. There were no significant differences in the diameter, dynamic enhancement patterns of the inner or outer nodules, or LI-RADS scores of the lesions between the hypointense group and the isointense group (all P > 0.05). Histologically, the inner nodules of NIN-HCCs were mainly composed of moderately differentiated HCC (75.9% 22/29), whereas the outer nodules consisted of either well-differentiated HCC or high-grade dysplastic nodules (HGDNs).

CONCLUSIONS

NIN-HCCs exhibit specific MRI findings closely associated with their pathological features. The spectrum of HBP enhancement patterns provides valuable insights into the underlying cell biological mechanisms of these lesions. NIN-HCC subtypes may be used as a morphologic marker in the early stage of multistep hepatocarcinogenesis.

摘要

目的

本研究旨在评估结节内结节型肝细胞癌(NIN-HCC)患者肝胆期(HBP)的强化模式和病理特征。

方法

这是一项单中心回顾性研究,纳入了 2016 年 1 月至 2023 年 9 月期间因肝硬化接受钆塞酸二钠增强 MRI 检查并经组织学证实为 29 个 NIN-HCC 的 27 例连续患者。两名盲法放射科医生评估了 NIN-HCC 内外结节的影像学特征,以达成对肝脏影像报告和数据系统(LI-RADS)病变类别的共识。根据 HBP 中外结节的不同强化模式,将 NIN-HCC 分为不同组,并进一步分为不同类型。随后比较了各组的影像学特征和 LI-RADS 类别。还评估了 NIN-HCC 的病理发现。

结果

在 29 个 NIN-HCC 中,所有内结节均表现为富血供,最大直径为 13.2±5.5mm;51.7%(15/29)表现为“快进快出”强化;48.3%(14/29)表现为“快进慢出”强化。所有外结节均表现为乏血供,最大直径为 25.6±7.3mm,51.9%(14/29)在门静脉期(PVP)呈洗脱表现。所有病变的最大直径为 27.5±6.8mm;12 个(41.4%)病变为 LR-4,17 个(58.6%)病变为 LR-5。根据 HBP 中外结节的信号强度,NIN-HCC 分为低信号(62.1%,18/29)和等信号(37.9%,11/29)两组。在低信号组中,2 个(6.9%)内结节表现为低信号(A 型),11 个(37.9%)表现为等信号(B 型),5 个(17.2%)表现为高信号(C 型),与背景低信号外结节相比。在等信号组中,9 个(31.0%)内结节表现为低信号(D 型),2 个(6.9%)表现为等信号(E 型),无(0%)表现为高信号(F 型),与背景等信号外结节相比。低信号组与等信号组之间,结节直径、内外结节的动态增强模式或病变的 LI-RADS 评分均无显著差异(均 P>0.05)。组织学上,NIN-HCC 的内结节主要由中分化 HCC 组成(75.9%,22/29),而外结节则由高分化 HCC 或高级别异型增生结节(HGDN)组成。

结论

NIN-HCC 具有特定的 MRI 表现,与病理特征密切相关。HBP 强化模式的范围为这些病变的细胞生物学机制提供了有价值的见解。NIN-HCC 亚型可能作为多步骤肝癌发生早期的形态学标志物。

相似文献

1
Nodule-in-nodule architecture of hepatocellular carcinomas: enhancement patterns in the hepatobiliary phase and pathological features.肝癌的结节内结节样结构:肝胆期强化模式和病理特征。
Abdom Radiol (NY). 2024 Nov;49(11):3834-3846. doi: 10.1007/s00261-024-04259-y. Epub 2024 Jun 24.
2
[Hepatobiliary phase image manifestation classification and pathological features of nodules in nodules accompanied by hepatocellular carcinoma].[伴有肝细胞癌的结节内结节的肝胆期图像表现分类及病理特征]
Zhonghua Gan Zang Bing Za Zhi. 2024 Nov 20;32(11):989-996. doi: 10.3760/cma.j.cn501113-20231221-00291.
3
Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation.肝胆期呈低血供低信号结节内高信号结节:转归及高血供转化率。
Eur J Radiol. 2019 Nov;120:108689. doi: 10.1016/j.ejrad.2019.108689. Epub 2019 Sep 20.
4
Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.多步骤肝癌发生过程中索拉非尼增强超声成像:与钆塞酸二钠增强MRI的比较
J Gastroenterol. 2014 Jun;49(6):1081-93. doi: 10.1007/s00535-013-0859-1. Epub 2013 Aug 1.
5
LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.LI-RADS v2014 肝细胞癌分类:钆喷酸葡胺增强 MRI 与钆塞酸二钠增强 MRI 的个体内比较。
Eur Radiol. 2019 Jan;29(1):401-410. doi: 10.1007/s00330-018-5559-z. Epub 2018 Jun 19.
6
Diagnostic performance of LR-5 based on hypointensity on Gd-EOB-DTPA-enhanced MRI in the hepatobiliary phase for sHCC using LI-RADS v2018 criteria.基于钆塞酸二钠增强MRI肝胆期低信号,采用LI-RADS v2018标准评估LR-5对小肝细胞癌的诊断效能。
Clin Radiol. 2025 Feb;81:106784. doi: 10.1016/j.crad.2024.106784. Epub 2024 Dec 19.
7
Gd-EOB-DTPA-enhanced MR imaging features of hepatocellular carcinoma in non-cirrhotic liver.非肝硬化肝脏中肝细胞癌的钆塞酸二钠增强磁共振成像特征。
Magn Reson Imaging. 2024 Dec;114:110241. doi: 10.1016/j.mri.2024.110241. Epub 2024 Oct 1.
8
Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.钆塞酸增强 MRI 肝胆期低信号结节无动脉期强化的放射-病理对照:多中心研究。
Radiology. 2020 Aug;296(2):335-345. doi: 10.1148/radiol.2020192275. Epub 2020 Jun 2.
9
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
10
Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.CT 和 MRI 鉴别肝胆期增强 MRI 显示高信号的肝细胞癌与局灶性结节增生。
AJR Am J Roentgenol. 2018 Aug;211(2):347-357. doi: 10.2214/AJR.17.19341. Epub 2018 Apr 30.

引用本文的文献

1
Identification of vessels encapsulating tumor clusters in solitary hepatocellular carcinoma via imaging biomarkers in preoperative contrast-enhanced magnetic resonance imaging.通过术前对比增强磁共振成像中的影像生物标志物识别孤立性肝细胞癌中包裹肿瘤簇的血管
Quant Imaging Med Surg. 2024 Dec 5;14(12):8586-8600. doi: 10.21037/qims-24-315. Epub 2024 Oct 17.

本文引用的文献

1
Threshold growth has a limited role in differentiating hepatocellular carcinoma from other focal hepatic lesions.阈值生长在区分肝细胞癌与其他局灶性肝病变方面作用有限。
BMC Med Imaging. 2023 Dec 4;23(1):201. doi: 10.1186/s12880-023-01161-9.
2
Molecular Pathological Characteristics of Thyroid Follicular-Patterned Tumors Showing Nodule-in-Nodule Appearance with Poorly Differentiated Component.呈现结节内结节外观且伴有低分化成分的甲状腺滤泡型肿瘤的分子病理学特征
Cancers (Basel). 2022 Jul 22;14(15):3577. doi: 10.3390/cancers14153577.
3
OATP1B3 Expression in Hepatocellular Carcinoma Correlates with Intralesional Gd-EOB-DTPA Uptake and Signal Intensity on Gd-EOB-DTPA-Enhanced MRI.
OATP1B3在肝细胞癌中的表达与病灶内钆塞酸二钠摄取及钆塞酸二钠增强MRI信号强度相关。
Cancer Manag Res. 2021 Feb 9;13:1169-1177. doi: 10.2147/CMAR.S292197. eCollection 2021.
4
Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.肝胆期肝脏病变呈高信号的谱系:基于临床背景的探讨方法
Insights Imaging. 2021 Jan 12;12(1):8. doi: 10.1186/s13244-020-00928-w.
5
Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study.直接作用抗病毒药物的引入对肝癌发生的影响:一项前瞻性系列随访 MRI 研究。
Aliment Pharmacol Ther. 2020 Jul;52(2):359-370. doi: 10.1111/apt.15825. Epub 2020 Jun 10.
6
Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.多步骤肝癌发生过程中与癌症相关的基因变化及其与影像学和组织学表现的相关性。
Hepatol Res. 2020 Sep;50(9):1071-1082. doi: 10.1111/hepr.13529. Epub 2020 Jun 30.
7
Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.钆塞酸增强磁共振成像在肝细胞癌中的应用:分子和遗传背景。
Eur Radiol. 2020 Jun;30(6):3438-3447. doi: 10.1007/s00330-020-06687-y. Epub 2020 Feb 16.
8
LI-RADS Version 2018 Ancillary Features at MRI.LI-RADS Version 2018 磁共振成像辅助特征。
Radiographics. 2018 Nov-Dec;38(7):1973-2001. doi: 10.1148/rg.2018180052. Epub 2018 Oct 5.
9
MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients.钆塞酸二钠增强磁共振成像在评估肝硬化患者肝脏结节中的应用
World J Hepatol. 2018 Jul 27;10(7):462-473. doi: 10.4254/wjh.v10.i7.462.
10
Hepatocarcinogenesis and LI-RADS.肝癌发生和 LI-RADS。
Abdom Radiol (NY). 2018 Jan;43(1):158-168. doi: 10.1007/s00261-017-1409-8.